PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
Abstract Background Immune checkpoint blockade targeting PD-1/PD-L1 has shown efficacy in several types of cancers. However, the correlation between PD-L1/PD-1 expression and the specific clinicopathological features in papillary thyroid carcinoma (PTC) has not been investigated. Methods We examined...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13000-017-0662-z |
id |
doaj-7d2eebdfbdaa42e29bbbb36d9e834765 |
---|---|
record_format |
Article |
spelling |
doaj-7d2eebdfbdaa42e29bbbb36d9e8347652020-11-25T00:44:41ZengBMCDiagnostic Pathology1746-15962017-10-011211810.1186/s13000-017-0662-zPD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinomaYanhua Bai0Dongfeng Niu1Xiaozheng Huang2Ling Jia3Qiang Kang4Fangyuan Dou5Xinqiang Ji6Weicheng Xue7Yiqiang Liu8Zhongwu Li9Qin Feng10Dongmei Lin11Kennichi Kakudo12Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Medical Statistics, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteDepartment of Pathology, Nara Hospital, Kindai University Faculty of MedicineAbstract Background Immune checkpoint blockade targeting PD-1/PD-L1 has shown efficacy in several types of cancers. However, the correlation between PD-L1/PD-1 expression and the specific clinicopathological features in papillary thyroid carcinoma (PTC) has not been investigated. Methods We examined the immunohistochemical expression of PD-L1, PD-1, and BRAF V600E on whole-tissue sections from 126 cases of primary PTC more than 1 cm in size. The correlation between the PD-L1/PD-1 expression and the clinicopathological features was evaluated. Results PD-L1 was positively expressed in 53.2% PTCs, and its expression was positively correlated with rich tumor-infiltrating lymphocytes (TILs), background chronic lymphocytic thyroiditis (CLT), female gender, absence of psammoma bodies, and PD-1 expression. Among these parameters, rich TILs, female gender, and absence of psammoma bodies were independent factors affecting PD-L1 expression on the multivariate logistic regression analysis. PD-1 expression was detected in the TILs and was positively correlated with rich TILs, background CLT, and absence of stromal calcification. Lack of stromal calcification was an independent factor affecting PD-1 expression. Neither PD-L1 nor PD-1 expression showed significant correlation with BRAF V600E expression. Conclusions Our results show that the distinctive pathological features of PTCs, including TILs, background CLT, female gender, psammoma bodies, and stromal calcification, are useful parameters for predicting PD-L1 or PD-1 expression.http://link.springer.com/article/10.1186/s13000-017-0662-zBRAF V600EChronic lymphocytic thyroiditisPapillary thyroid carcinomaPD-1PD-L1Tumor-infiltrating lymphocytes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yanhua Bai Dongfeng Niu Xiaozheng Huang Ling Jia Qiang Kang Fangyuan Dou Xinqiang Ji Weicheng Xue Yiqiang Liu Zhongwu Li Qin Feng Dongmei Lin Kennichi Kakudo |
spellingShingle |
Yanhua Bai Dongfeng Niu Xiaozheng Huang Ling Jia Qiang Kang Fangyuan Dou Xinqiang Ji Weicheng Xue Yiqiang Liu Zhongwu Li Qin Feng Dongmei Lin Kennichi Kakudo PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma Diagnostic Pathology BRAF V600E Chronic lymphocytic thyroiditis Papillary thyroid carcinoma PD-1 PD-L1 Tumor-infiltrating lymphocytes |
author_facet |
Yanhua Bai Dongfeng Niu Xiaozheng Huang Ling Jia Qiang Kang Fangyuan Dou Xinqiang Ji Weicheng Xue Yiqiang Liu Zhongwu Li Qin Feng Dongmei Lin Kennichi Kakudo |
author_sort |
Yanhua Bai |
title |
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma |
title_short |
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma |
title_full |
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma |
title_fullStr |
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma |
title_full_unstemmed |
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma |
title_sort |
pd-l1 and pd-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma |
publisher |
BMC |
series |
Diagnostic Pathology |
issn |
1746-1596 |
publishDate |
2017-10-01 |
description |
Abstract Background Immune checkpoint blockade targeting PD-1/PD-L1 has shown efficacy in several types of cancers. However, the correlation between PD-L1/PD-1 expression and the specific clinicopathological features in papillary thyroid carcinoma (PTC) has not been investigated. Methods We examined the immunohistochemical expression of PD-L1, PD-1, and BRAF V600E on whole-tissue sections from 126 cases of primary PTC more than 1 cm in size. The correlation between the PD-L1/PD-1 expression and the clinicopathological features was evaluated. Results PD-L1 was positively expressed in 53.2% PTCs, and its expression was positively correlated with rich tumor-infiltrating lymphocytes (TILs), background chronic lymphocytic thyroiditis (CLT), female gender, absence of psammoma bodies, and PD-1 expression. Among these parameters, rich TILs, female gender, and absence of psammoma bodies were independent factors affecting PD-L1 expression on the multivariate logistic regression analysis. PD-1 expression was detected in the TILs and was positively correlated with rich TILs, background CLT, and absence of stromal calcification. Lack of stromal calcification was an independent factor affecting PD-1 expression. Neither PD-L1 nor PD-1 expression showed significant correlation with BRAF V600E expression. Conclusions Our results show that the distinctive pathological features of PTCs, including TILs, background CLT, female gender, psammoma bodies, and stromal calcification, are useful parameters for predicting PD-L1 or PD-1 expression. |
topic |
BRAF V600E Chronic lymphocytic thyroiditis Papillary thyroid carcinoma PD-1 PD-L1 Tumor-infiltrating lymphocytes |
url |
http://link.springer.com/article/10.1186/s13000-017-0662-z |
work_keys_str_mv |
AT yanhuabai pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT dongfengniu pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT xiaozhenghuang pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT lingjia pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT qiangkang pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT fangyuandou pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT xinqiangji pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT weichengxue pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT yiqiangliu pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT zhongwuli pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT qinfeng pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT dongmeilin pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma AT kennichikakudo pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma |
_version_ |
1725274141334962176 |